newsroom
 
 
News archives


JULY - SEPTEMBER 17

APRIL - JUNE 17

JANUARY - MARCH 17

OCTOBER - DECEMBER 16

JULY - SEPTEMBER 16

APRIL - JUNE 16

JANUARY - MARCH 16

OCTOBER - DECEMBER 15

JULY - SEPTEMBER 15

APRIL - JUNE 15

JANUARY - MARCH 15

OCTOBER - DECEMBER 14

JULY - SEPTEMBER 14

APRIL - JUNE 14

JANUARY - MARCH 14

OCTOBER - DECEMBER 13

JULY - SEPTEMBER 13

APRIL - JUNE 13

JANUARY - MARCH 13

OCTOBER - DECEMBER 12

JULY - SEPTEMBER 12

APRIL - JUNE 12

JANUARY - MARCH 12

OCTOBER - DECEMBER 11

JULY - SEPTEMBER 11

APRIL - JUNE 11

JANUARY - MARCH 11

OCTOBER - DECEMBER 10

JULY - SEPTEMBER 10

APRIL - JUNE 10

JANUARY - MARCH 10

OCTOBER - DECEMBER 09

JULY - SEPTEMBER 09

APRIL - JUNE 09

JANUARY - MARCH 09

OCTOBER - DECEMBER 08

JULY - SEPTEMBER 08

APRIL - JUNE 08

JANUARY - MARCH 08

OCTOBER - DECEMBER 07

JULY - SEPTEMBER 07

APRIL - JUNE 07

JANUARY - MARCH 07

 
  current news   Press   Selected Archive    
     
  JULY - SEPTEMBER 16  
 
  27 September 2016
 

Long-range chromatin interactions drive mutant Tert promoter activation

Full Story


  20 September 2016
 

Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression

Full Story


  14 September 2016
 

The genome of the largest bony fish, ocean sunfish (Mola mola), provides insights into its fast growth rate

Full Story


  7 September 2016
 

Proline isomerisation as a novel regulatory mechanism for p38MAPK activation and functions

Full Story


  22nd August 2016
 

Single-cell multimodal profiling reveals cellular epigenetic heterogeneity

Full Story



  15th August 2016
 

Two-Step Forward Genetic Screen in Mice Identifies Ral GTPase-Activating Proteins as Suppressors of Hepatocellular Carcinoma

Full Story



  5th August 2016
 

Analyzing tumor heterogeneity and driver genes in single myeloid leukemia cells with SBCapSeq

Full Story



  22nd July 2016
 

Structural basis of suppression of host translation termination by Moloney Murine Leukemia Virus

Full Story



  8th July 2016
 

Structural basis for blocking PD-1 mediated immune response by therapeutic antibody pembrolizumab

Full Story